| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.008 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |